首页> 外文期刊>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics >Are we on the brink of nonsurgical treatment for ameloblastoma?
【24h】

Are we on the brink of nonsurgical treatment for ameloblastoma?

机译:我们正处于非手术治疗成釉细胞瘤的边缘吗?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Recent identification of altered molecular signaling pathways in neoplasia has begun to elucidate mechanisms of oncogenesis, differentiation, and tumor progression, and to suggest plausible nonsurgical considerations for treatment. Here we review the sonic hedgehog (SHH) and PI3K/Akt/mTOR signaling pathways, their role in ameloblastoma, a locally aggressive odontogenic tumor, and evidence for consideration of therapeutic approaches that target these molecular pathways. In so doing, some of the gaps will be revealed that may impel investigations and translate to patient care, helping to minimize or eliminate the need for extensive surgery. STUDY DESIGN: This is a comprehensive review of the literature regarding alterations in signaling mechanisms associated with ameloblastomas. In addition, this review attempts to explore and discuss possible inhibitors to these pathways that may have utility in treating ameloblastoma. RESULTS: The expression of SHH signaling molecules in ameloblastomas at the mRNA and protein levels has intimated that these molecules may play a role in cell proliferation of these tumors. Immunohistochemical analysis has revealed aberrant signaling in the PI3K/Akt/mTOR pathway in ameloblastomas and appears to be a valuable tool for elucidating pathogenesis and aggressiveness, and selecting optimal therapeutics. CONCLUSION: The understanding of altered pathways in ameloblastoma may soon provide nonsurgical options for the treatment of this condition. The demonstration of cross talk in SHH signal transduction with PI3K signaling through Akt has shown that these pathways converge to control the Gli transcription factors. Thus, tumors that entirely depend on active SHH signaling for survival/growth and maintenance may well be susceptible targets for combined chemotherapy with SHH-specific inhibitors together with PI3K, Akt, or mTOR blocking agents. Some of these inhibitors could be used locally, thereby minimizing major systemic effects.
机译:目的:最近鉴定的肿瘤形成中分子信号通路的改变已开始阐明肿瘤发生,分化和肿瘤进展的机制,并提出了可能的非手术治疗方法。在这里,我们回顾了声波刺猬(SHH)和PI3K / Akt / mTOR信号通路,它们在成釉细胞瘤,局部侵袭性牙源性肿瘤中的作用以及考虑针对这些分子通路的治疗方法的证据。这样一来,就会发现一些差距,这些差距可能会推动研究并转化为患者护理,从而有助于最大程度地减少或消除对广泛手术的需求。研究设计:这是有关成釉细胞瘤相关信号传导机制改变的文献的全面综述。另外,本综述试图探索和讨论这些途径的可能抑制剂,这些抑制剂可能在治疗成釉细胞瘤中具有实用性。结果:SHH信号分子在成纤维细胞瘤中的mRNA和蛋白水平表达已暗示这些分子可能在这些肿瘤的细胞增殖中起作用。免疫组织化学分析显示,成釉细胞瘤中PI3K / Akt / mTOR途径异常信号传导,似乎是阐明发病机理和侵袭性并选择最佳疗法的有价值的工具。结论:对成釉细胞瘤途径改变的了解可能很快会为该病的治疗提供非手术选择。 SHH信号转导与通过Akt进行的PI3K信号转导中的串扰演示表明,这些途径可以收敛以控制Gli转录因子。因此,完全依赖于活性SHH信号的存活/生长和维持的肿瘤很可能是SHH特异性抑制剂与PI3K,Akt或mTOR阻断剂联合化疗的敏感靶标。这些抑制剂中的某些可以局部使用,从而最大程度地减少了全身性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号